Login
Home
Charts
Search
Watchlist
Products

Avantel Ltd

AVANTEL·NSE
146.49+1.02%Tue, 22 Sept '26 11:43

Avantel Ltd

AVANTEL
NSE
146.49
+1.02%
|Tue, 22 Sept '26 11:43
SOICxStockScans Reports
6M
Price
Charts
Documents

Quick Ratios

Edit Ratios
Mkt Cap
Market Capitalization
3,893Cr
Close
Close Price
146.49
Industry
Industry
Aerospace & Defence - Equipments
PE
Price To Earnings
206.32
PS
Price To Sales
16.13
Revenue
Revenue
241Cr
Rev Gr TTM
Revenue Growth TTM
-3.16%
PAT Gr TTM
PAT Growth TTM
-67.16%

Quarterly Results

Consolidated
Standalone
Numbers
Percentage
QuarterSep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Revenue
RevenueCr
545942527771495255526470
Growth YoY
Revenue Growth YoY%
50.053.3-20.5-24.942.519.118.00.3-28.4-26.829.635.7
Expenses
ExpensesCr
293524384339384144395053
Operating Profit
Operating ProfitCr
252418143532121011131417
OPM
OPM%
45.941.243.527.444.845.323.620.120.424.321.324.8
Other Income
Other IncomeCr
000001001010
Interest Expense
Interest ExpenseCr
210111111222
Depreciation
DepreciationCr
222333345567
PBT
PBTCr
222216113228856679
Tax
TaxCr
664498222333
PAT
PATCr
16161272320634355
Growth YoY
PAT Growth YoY%
161.7143.926.2-7.942.523.0-50.0-56.2-81.3-86.3-21.666.9
NPM
NPM%
29.627.529.114.329.628.412.36.27.75.37.57.7
EPS
EPS
0.60.60.50.30.90.80.20.10.10.10.30.2
QuarterSep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Revenue
RevenueCr
545942527771495255526470
Growth YoY
Revenue Growth YoY%
50.053.3-20.5-24.942.519.118.00.3-28.4-26.829.635.7
Expenses
ExpensesCr
293524384339384144395053
Operating Profit
Operating ProfitCr
252418143532121011131417
OPM
OPM%
45.941.243.527.444.845.323.620.120.424.321.324.8
Other Income
Other IncomeCr
000001001010
Interest Expense
Interest ExpenseCr
210111111222
Depreciation
DepreciationCr
222333345567
PBT
PBTCr
222216113228856679
Tax
TaxCr
664498222333
PAT
PATCr
16161272320634355
Growth YoY
PAT Growth YoY%
161.7143.926.2-7.942.523.0-50.0-56.2-81.3-86.3-21.666.9
NPM
NPM%
29.627.529.114.329.628.412.36.27.75.37.57.7
EPS
EPS
0.60.60.50.30.90.80.20.10.10.10.30.2

Profit & Loss

Consolidated
Standalone
Numbers
Percentage
Financial YearMar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Revenue
RevenueCr
78105154224249223241
Growth
Revenue Growth%
35.147.245.311.0-10.5-3.2
Expenses
ExpensesCr
5678108143157175186
Operating Profit
Operating ProfitCr
22274782934855
OPM
OPM%
28.525.430.336.537.121.522.7
Other Income
Other IncomeCr
1101223
Interest Expense
Interest ExpenseCr
2254367
Depreciation
DepreciationCr
3468122023
PBT
PBTCr
19223772792528
Tax
TaxCr
341019231011
PAT
PATCr
15182753561517
Growth
PAT Growth%
17.249.395.87.4-73.4-67.2
NPM
NPM%
19.717.117.423.422.76.77.1
EPS
EPS
0.60.71.12.02.32.40.7
Financial YearMar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Revenue
RevenueCr
78105154224249223241
Growth
Revenue Growth%
35.147.245.311.0-10.5-3.2
Expenses
ExpensesCr
5678108143157175186
Operating Profit
Operating ProfitCr
22274782934855
OPM
OPM%
28.525.430.336.537.121.522.7
Other Income
Other IncomeCr
1101223
Interest Expense
Interest ExpenseCr
2254367
Depreciation
DepreciationCr
3468122023
PBT
PBTCr
19223772792528
Tax
TaxCr
341019231011
PAT
PATCr
15182753561517
Growth
PAT Growth%
17.249.395.87.4-73.4-67.2
NPM
NPM%
19.717.117.423.422.76.77.1
EPS
EPS
0.60.71.12.02.32.40.7

Balance Sheet

Consolidated
Standalone
Numbers
Percentage
Financial YearMar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital
Equity CapitalCr
4416494953
Reserves
ReservesCr
627891115188285
Current Liabilities
Current LiabilitiesCr
172238453559
Non Current Liabilities
Non Current LiabilitiesCr
44471813
Total Liabilities
Total LiabilitiesCr
87109149216290410
Current Assets
Current AssetsCr
6572108146167218
Non Current Assets
Non Current AssetsCr
22374270123192
Total Assets
Total AssetsCr
87109149216290410
Financial YearMar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital
Equity CapitalCr
4416494953
Reserves
ReservesCr
627891115188285
Current Liabilities
Current LiabilitiesCr
172238453559
Non Current Liabilities
Non Current LiabilitiesCr
44471813
Total Liabilities
Total LiabilitiesCr
87109149216290410
Current Assets
Current AssetsCr
6572108146167218
Non Current Assets
Non Current AssetsCr
22374270123192
Total Assets
Total AssetsCr
87109149216290410

Cash Flow

Consolidated
Standalone
Financial YearMar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating Cash Flow
Operating Cash FlowCr
45-322655010
Investing Cash Flow
Investing Cash FlowCr
-4223-10-42-57-93
Financing Cash Flow
Financing Cash FlowCr
-398-23886
Net Cash Flow
Net Cash FlowCr
000114
Free Cash Flow
Free Cash FlowCr
40-47-944-28-81
CFO To PAT
CFO To PAT%
291.2-179.86.2124.088.467.0
CFO To EBITDA
CFO To EBITDA%
201.4-121.33.679.753.921.0
Financial YearMar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating Cash Flow
Operating Cash FlowCr
45-322655010
Investing Cash Flow
Investing Cash FlowCr
-4223-10-42-57-93
Financing Cash Flow
Financing Cash FlowCr
-398-23886
Net Cash Flow
Net Cash FlowCr
000114
Free Cash Flow
Free Cash FlowCr
40-47-944-28-81
CFO To PAT
CFO To PAT%
291.2-179.86.2124.088.467.0
CFO To EBITDA
CFO To EBITDA%
201.4-121.33.679.753.921.0

Ratios

Consolidated
Standalone
Financial YearMar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026Current
Valuation Ratios
Valuation Ratios
Market Cap
Market CapitalizationCr
1534156552,4082,7753,3603,893
Price To Earnings
Price To Earnings
10.023.124.445.849.1225.8206.3
Price To Sales
Price To Sales
2.04.04.210.711.115.116.1
Price To Book
Price To Book
2.35.06.114.711.79.911.5
EV To EBITDA
EV To EBITDA
5.116.114.629.530.270.771.7
Profitability Ratios
Profitability Ratios
GPM
GPM%
53.447.750.458.065.356.856.8
OPM
OPM%
28.525.430.336.537.121.522.7
NPM
NPM%
19.717.117.423.422.76.77.1
ROCE
ROCE%
28.924.430.141.731.38.18.1
ROE
ROE%
23.121.825.032.023.84.44.4
ROA
ROA%
17.716.518.024.419.53.73.7
Operational Ratios
Operational Ratios
Solvency Ratios
Solvency Ratios
Liquidity Ratios
Liquidity Ratios
Financial YearMar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026Current
Valuation Ratios
Valuation Ratios
Market Cap
Market CapitalizationCr
1534156552,4082,7753,3603,893
Price To Earnings
Price To Earnings
10.023.124.445.849.1225.8206.3
Price To Sales
Price To Sales
2.04.04.210.711.115.116.1
Price To Book
Price To Book
2.35.06.114.711.79.911.5
EV To EBITDA
EV To EBITDA
5.116.114.629.530.270.771.7
Profitability Ratios
Profitability Ratios
GPM
GPM%
53.447.750.458.065.356.856.8
OPM
OPM%
28.525.430.336.537.121.522.7
NPM
NPM%
19.717.117.423.422.76.77.1
ROCE
ROCE%
28.924.430.141.731.38.18.1
ROE
ROE%
23.121.825.032.023.84.44.4
ROA
ROA%
17.716.518.024.419.53.73.7
Operational Ratios
Operational Ratios
Solvency Ratios
Solvency Ratios
Liquidity Ratios
Liquidity Ratios
Avantel is an Indian defence-electronics company that designs and builds its own communication and radar systems for the armed forces, owning the intellectual property rather than competing on manufacturing scale. Founded in 1990 by Dr. Abburi Vidyasagar, it has spent three decades moving from wireless products into software-defined radios, satellite terminals, and radar - all developed in-house by its R&D wing. The recurring approach is to develop customised, state-of-the-art products for specific Indian defence requirements, often securing a captive buyer through government innovation schemes before a product is even built. # Business segments Two engines at different stages - a defence-communications powerhouse that is the entire standalone business, and a healthcare-device subsidiary still in its consolidation phase - both built on the same in-house R&D philosophy. ## 1. Communications and Signal Processing: the defence-electronics core **Every rupee of standalone revenue comes from indigenous communication and radar systems sold to the Indian military, space agency and railways - products the company designs, certifies and manufactures itself.** - **Built, not bought** - all products are developed through indigenous R&D with no technology imported in the past three years; the R&D centre is government-recognised and spent ₹1,739.69 Lakhs in FY26, about 7.86% of turnover. - **Radios that define themselves** - the company makes Software Defined Radios (SDRs) across HF, VHF and UHF bands for land, sea and air platforms, compliant with SCA 4.1 architecture, and has already received orders from DRDO and other defence entities. - **Satellite links for ships and helicopters** - its Mobile Satellite Services terminals work on Indian geostationary satellites with anti-jamming capability and are supplied to the Indian Navy, Coast Guard and shipbuilders; it also developed SATCOM systems for Lockheed Martin helicopters being delivered to the Indian Navy. - **The iDEX captive-market advantage** - under the Innovations for Defence Excellence scheme, the company has won the maximum five challenges in the space domain, which means the procuring agency must buy a minimum quantity from Avantel after successful development, creating a sole-source pathway. - **From trains to fishing boats** - beyond pure defence, the engine delivered 6,300 loco units for Indian Railways' Real Time Train Information System under a ₹125.68 Crore contract from L&T, and supplies fishing transponders to the Department of Fisheries through NewSpace India Limited. - **Three plants, one moat** - a Visakhapatnam facility handles production of MSS, UHF radios and HF systems; a new Hyderabad E-City facility (operational October 2025) houses R&D, radar work and a satellite Assembly, Integration and Test unit; and a Vijayawada plant under construction will build antennas up to 11 metres in diameter. - **Certifications as barriers** - the company holds AS9100:2016 (aerospace quality), ISO/IEC 27001:2022 (information security), NABL-accredited in-house environmental testing, and other defence-grade certifications that new entrants cannot easily replicate. ## 2. Healthcare Services: a medical-device bet in waiting **A wholly owned subsidiary building respiratory and surgical devices from a dedicated MedTech Zone facility - still in consolidation, with no standalone revenue contribution disclosed.** - **A separate company, a separate factory** - Imeds Global Private Limited was incorporated in September 2021 and operates from a 2-acre, 36,000 sq ft facility at the Andhra Pradesh MedTech Zone in Visakhapatnam, equipped with clean rooms and testing infrastructure. - **Respiratory and surgical portfolio** - products under development include disposable skin staplers and removers, a non-invasive ventilator that was at an advanced stage as of FY23, a patient monitor, and a syringe pump. - **Import substitution play** - the subsidiary has been granted a manufacturing license for surgical staplers and removers, and plans to launch respiratory and other import-substitution products. - **Still finding its feet** - the facility was scheduled to become operational from June 2025 but the inauguration was postponed; products including ventilators and patient monitors were expected to be certified during FY25. # Group structure and partners **A promoter-led holding company with one subsidiary, deep family management, and a network of global defence relationships.** - **Promoter-driven, professionally overseen** - the Abburi family (Dr. Abburi Vidyasagar as Chairman & MD, Smt. Abburi Sarada and Shri Abburi Siddhartha Sagar as Whole-Time Directors) collectively held 40.36% as of FY21, while independent directors include a retired R&D head from Bharat Electronics and a retired LIC Managing Director. - **One subsidiary, fully owned** - Imeds Global Private Limited is the only subsidiary, with Avantel holding 100% of its equity and having invested ₹1,175 Lakhs as of March 2023. - **Global partners on specific programmes** - the company plans to procure a ground station antenna from Safran of France, has supplied helicopter SATCOM units to Lockheed Martin for Indian Navy platforms, and collaborates with L&T as a lead system integrator on railway projects. - **Employee ownership aligned** - two Employee Stock Option Plans (2023 and 2025) together cover up to 90,00,000 equity shares.

Documents — Avantel Ltd

  • Q1 FY2026 Earnings Call Transcript (Jun 2025, PDF): https://www.stockscans.in/document/c41vxjipjlkx898fkthtq734.pdf
  • Q1 FY2027 Quarterly Result (Jun 2026, PDF): https://www.stockscans.in/document/n0j7a8shjnzhhzh5ssjwpwk3.pdf
  • Q4 FY2026 Quarterly Result (Mar 2026, PDF): https://www.stockscans.in/document/pydrwkcfksc2b2gh44cdfypu.pdf
  • Q3 FY2026 Quarterly Result (Dec 2025, PDF): https://www.stockscans.in/document/p7j60zdkc8guf2pvr6fjttlc.pdf
  • Q2 FY2026 Quarterly Result (Sep 2025, PDF): https://www.stockscans.in/document/tebx4xn78xtp1st6q8n2gijh.pdf
  • Q1 FY2026 Quarterly Result (Jun 2025, PDF): https://www.stockscans.in/document/2cbu19lx0s87lxrs4k3qvdb6.pdf
  • Q4 FY2025 Quarterly Result (Mar 2025, PDF): https://www.stockscans.in/document/dtpgegb8s0g3l6rhn1ranpbe.pdf
  • Q3 FY2025 Quarterly Result (Dec 2024, PDF): https://www.stockscans.in/document/brbr6gpj4mrvq2xi0rswert1.pdf
  • Q2 FY2025 Quarterly Result (Sep 2024, PDF): https://www.stockscans.in/document/4zdgk2evw1j2jjvx67objm5f.pdf
  • FY2026 Annual Report (PDF): https://www.stockscans.in/document/8th1hfmiyniqg8jeuytyttg3.pdf
  • FY2025 Annual Report (PDF): https://www.stockscans.in/document/dexgfi2tb8ypdupj9m02pbw9.pdf
  • FY2024 Annual Report (PDF): https://www.stockscans.in/document/qi9929225oczgy52c7o61u7v.pdf
  • FY2023 Annual Report (PDF): https://www.stockscans.in/document/8yu40tgez2srr0pxybi99coo.pdf
  • FY2022 Annual Report (PDF): https://www.stockscans.in/document/dw0n9x1zdohp01uxa097yvpt.pdf
  • FY2021 Annual Report (PDF): https://www.stockscans.in/document/b2vlcd70dh73i3zdzjnpjpv1.pdf

Concall Transcript Summaries — Avantel Ltd

  • Q1 FY2026 Concall Transcript Summary (Jun 2025): https://www.stockscans.in/company/NSE%3AAVANTEL/transcript-notes/202506/c41vxjipjlkx898fkthtq734.pdf